MDY - SPDR S&P MidCap 400 ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
366.22
+1.85 (+0.51%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close364.37
Open363.80
Bid0.00 x 900
Ask0.00 x 900
Day's Range363.19 - 366.51
52 Week Range307.28 - 368.25
Volume495,424
Avg. Volume844,441
Net Assets20.69B
NAV361.09
PE Ratio (TTM)N/A
Yield1.28%
YTD Return5.08%
Beta (3y)0.95
Expense Ratio (net)0.24%
Inception Date1995-05-04
Trade prices are not sourced from all markets
  • Chartmaster Carter Worth says forget big tech, buy this g...
    CNBC Videos11 months ago

    Chartmaster Carter Worth says forget big tech, buy this g...

    Carter Worth, Cornerstone Macro, discusses how to trade technology after the sector dipped. The “Fast Money” traders weigh in.

  • ETF Trends18 days ago

    It’s Time to Revisit Mid-Cap ETFs

    Mid-cap stocks and exchange traded funds, such as the SPDR Mid-Cap 400 (MDY) , are lagging their large- and small-cap counterparts this year. Some market observers believe that scenario is poised to change. Mid-cap companies are slightly more diversified than their small-cap peers, which allows many mid-sized companies to generate more consistent revenue and cash flow, along with providing more stable stock prices.

  • ETF Trends25 days ago

    SSGA is Teaming Up With Actress Elizabeth Banks

    State Street Global Advisors, the asset management business of State Street Corporation, has teamed up with actress, director and business owner Elizabeth Banks to launch a series of podcasts to raise awareness of the strong performance of several mid-cap companies that make up the SPDR® S&P MIDCAP 400 ETF (MDY) . The series, entitled "Crazy Enough to Work," was directed by David Gordon Green and explores how several companies with a market cap range of $1 billion to $8 billion began, overcame obstacles and remain relevant as the world changes around them. During several frank discussions and fun experiences, Elizabeth Banks investigates and uncovers unexpected moments about how these companies have influenced and inspired their customers and employees.

  • Investopedia2 months ago

    Mid-Cap ETFs: Great Performance, Little Interest?

    Sometimes, an excellent investment opportunity seems to hide in plain sight. Exchange-traded funds (ETFs) that track U.S. mid-cap companies may be one of those missed opportunities, according to a recent report by Bloomberg Businessweek. Indeed, Bloomberg Intelligence ETF analyst Eric Balchunas says that MDY would be the best bet among any ETF in history based on performance.

  • ETF Trends2 months ago

    Mid-Cap ETFs Need Love, Too

    Mid-cap stocks and exchange traded funds, such as the SPDR Mid-Cap 400 (NYSEArca: MDY), off the potential to outperform large-caps with less volatility than small-caps over the long-term, but many investors ...

  • Investopedia3 months ago

    The Most Important Trends in the U.S. Stock Market Now

    The Nasdaq Composite, on the other hand, reached its upside objective of 7600 in January and has been consolidating below that level ever since. Was that the move, and now we reverse from this key extension target? Or should we instead focus on the fact that the Nasdaq just went out at an all-time monthly closing high, which is a characteristic of an uptrend, not a downtrend?

  • What to Make of the Decline of Consumer Expectations in April
    Market Realist3 months ago

    What to Make of the Decline of Consumer Expectations in April

    The Conference Board Leading Economic Index (or LEI) has ten constituent indicators, and all but one of these forward-looking indicators is based on expectations. This economic indicator used in the construction of the LEI is based on consumer expectations. This economic indicator is based on two different consumer surveys.

  • 7 Best Ways To Gauge How The Stock Market Is Doing
    Investor's Business Daily3 months ago

    7 Best Ways To Gauge How The Stock Market Is Doing

    Whether you have your heart set on Apple or Facebook, Alibaba or Baidu, or a domestic vs. foreign stock, you can access them all via ETFs.

  • 3 Covered Calls to Hedge the Market
    InvestorPlace4 months ago

    3 Covered Calls to Hedge the Market

    One of the ways that you can hedge your long-term position is by selling covered calls. Selling covered calls is a options trade in which you agree for another investor to buy a given stock or ETF from you that you own at a particular strike price on or before the contract expiration date. Usually the stock is not sold — also known as called away — unless the closing price of the stock or ETF is above the contract strike price on the contract expiration date.

  • What to Make of Another Uptick in Consumer Expectations
    Market Realist4 months ago

    What to Make of Another Uptick in Consumer Expectations

    What Do March Leading Indicators Signal for the US Economy? The Conference Board Leading Economic Index (or LEI) has ten constituent indicators, and all but one of these forward-looking indicators are based on expectations. The average consumer expectations for business is not a forward indicator as it is derived using expectations, rather than any economic indicator.

  • Analyzing Oil and the US Equity Market
    Market Realist4 months ago

    Analyzing Oil and the US Equity Market

    Is the Equity Market Helping Your Energy Portfolio?

  • Investopedia5 months ago

    Shorts Get Aggressive With Mid-Cap, Tech ETFs

    Short sellers are targeting the usual suspects among ETFs along with renewed interest in tech and mid-cap funds.

  • Weekly ETF Roundup: International & Bond Win, US Equity Lags
    Zacks6 months ago

    Weekly ETF Roundup: International & Bond Win, US Equity Lags

    Inside the ETFs that gained investor's attraction last week.

  • ETF Trends6 months ago

    A Look At Mighty Mid-Caps

    Mid-cap stocks and exchange traded funds, such as the SPDR Mid-Cap 400 (NYSEArca: MDY), can go often go overlooked relative to large- and small-cap fare, but this market cap segment has a history of delivering ...

  • ETF Trends6 months ago

    Mid-Cap ETFs Can Get a Weak Dollar Boost

    It is often said that large-caps, many of which are multi-national firms generating significant portions of their revenue overseas, benefit from a weak dollar while smaller companies, due to their domestic ...

  • 3 ETF Covered Calls to Earn Extra Income
    InvestorPlace7 months ago

    3 ETF Covered Calls to Earn Extra Income

    With covered calls, you are selling the right for someone else to buy a security from you at a given price on or before a certain date. If you sell covered calls on a stock and that contract gets triggered because the price has gone above that contract’s strike price, you will be forced to sell the stock. The SPDR S&P 500 ETF (NYSEARCA:SPY) is that core ETF that many people own, one which holds all the stocks in the S&P 500.

  • Four challenges facing investors before Santa comes to town: trader
    Yahoo Finance9 months ago

    Four challenges facing investors before Santa comes to town: trader

    With just 28 trading days left in 2017, investors have a lot to be thankful for this holiday season. Each news cycle presents an additional challenge for tax reform legislation as it makes its way to the president’s desk. Politics aside, some measure of a tax reform package is priced into the market, and a complete failure would force a reset.

  • ETF.com11 months ago

    Least Popular ETFs Of The Year

    It may be surprising to hear that in a year in which ETFs are shattering all sorts of records with regard to the amount of money they are taking in, the world's largest exchange-traded fund isn't participating in the bonanza. That's right; the SPDR S&P 500 ETF Trust (SPY), the $242 billion behemoth, has actually had net outflows this year to the tune of $4.2 billion.

  • Market Realist11 months ago

    How Are Bioverativ’s Key Drugs Positioned after 2Q17?

    In 2Q17, Bioverativ’s Alprolix generated revenues of ~$89.7 million, which represents ~12% growth YoY (year-over-year) and ~4% growth sequentially.

  • Market Realistlast year

    How Did United Therapeutics’ Orenitram and Unituxin Perform in 2Q17?

    In 2Q17, United Therapeutics’ (UTHR) Unituxin generated revenues of around $16 million, a 10% decline on a year-over-year (or YoY) basis and an 11% decline on a quarter-over-quarter basis.

  • Time to Buy Mid-Cap ETFs?
    Zackslast year

    Time to Buy Mid-Cap ETFs?

    With large-cap stocks volatile on Trump-Kim Jong-un rift and small-caps having chances of underperformance on some weak U.S. economic data, should you buy mid-cap ETFs?